跳至主要内容
临床试验/NL-OMON44398
NL-OMON44398已完成不适用

An open-label, randomized, crossover, phase 1 study to evaluate bioequivalence and relative bioavailability between JZP-507 commercial scale and pilot oral solutions in healthy subjects - JZP-507 BA BE study

Jazz Pharmaceuticals, inc.0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - healthy male or female
  • - between 18 and 45 years of age, inclusive
  • - BMI is between 20 and 30 kilograms/meter2, inclusive, with a body weight at least 60 kilograms

排除标准

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. Has used any other investigational drug within 30 days or five half-lives (whichever is longer) before dosing, or plans to use an investigational drug (other than the study drug) during the study. Has donated >50 mL of blood within 60 days of randomization.

研究者

相似试验

已完成
不适用
An open-label, randomized, crossover phase 1 clinical trial to evaluate the safety, pharmacokinetic characteristics and the effect of food after administration of ABN401 in healthy adult volunteersNeoplasms
KCT0007131Chungbuk National University Hospital24
进行中(未招募)
1 期
A study to assess the food effect and how fast JNJ-53718678 reaches the blood stream of healthy adult subjects after being dosed with 250-mg as an oral solid concept compared with suspension; and the effect of storage conditions on how long the drug stays and acts in the body after administration of JNJ-53718678Respiratory Syncytial VirusMedDRA version: 20.0Level: HLTClassification code 10038717Term: Respiratory syncytial viral infectionsSystem Organ Class: 100000004862
EUCTR2020-000369-18-BEJanssen Sciences Ireland Unlimited Company (UC)84
已完成
不适用
A Phase I, open label, randomized, crossover trial in healthy subjects to investigate the pharmacokinetic interaction between didanosine and TMC114, coadministered with low-dose ritonavir, at steady-state.human immunodeficiency virus (aids)10021460
NL-OMON29874Tibotec Pharmaceuticals18
进行中(未招募)
不适用
AHIV-1 infectionMedDRA version: 14.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2011-004159-38-BEJanssen R&D Ireland
进行中(未招募)
1 期
A Study to Evaluate the Relative Bioavailability of Tezacaftor/Ivacaftor GranulesMedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2020-000689-40-Outside-EU/EEAVertex Pharmaceuticals Incorporated16
An open-label, randomized, crossover, phase 1 study... | 临床试验